Logo image of CHN

CHINA FUND INC (CHN) Stock Overview

USA - NYSE:CHN - US1693731077

18.15 USD
-0.11 (-0.6%)
Last: 10/24/2025, 8:15:14 PM
18.22 USD
+0.07 (+0.39%)
After Hours: 10/24/2025, 8:15:14 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CHN. CHN was compared to 0 industry peers in the Unkown industry. Both the profitability and financial health of CHN have multiple concerns. CHN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CHN had positive earnings in the past year.
In the past year CHN had a positive cash flow from operations.
Of the past 5 years CHN 4 years were profitable.
Of the past 5 years CHN 4 years had a positive operating cash flow.
CHN Yearly Net Income VS EBIT VS OCF VS FCFCHN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

Industry RankSector Rank
ROA 13.94%
ROE 14.04%
ROIC 1.15%
ROA(3y)-23.62%
ROA(5y)-7.32%
ROE(3y)-24.16%
ROE(5y)-7.37%
ROIC(3y)N/A
ROIC(5y)N/A
CHN Yearly ROA, ROE, ROICCHN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

CHN's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of CHN has grown nicely.
CHN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 49.75%
PM (TTM) 476.38%
GM 66.58%
OM growth 3Y37.66%
OM growth 5Y7.39%
PM growth 3Y41.82%
PM growth 5Y-6.33%
GM growth 3Y23.66%
GM growth 5Y3.51%
CHN Yearly Profit, Operating, Gross MarginsCHN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K -4K -6K

3

2. Health

2.1 Basic Checks

CHN has less shares outstanding than it did 1 year ago.
CHN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CHN is higher compared to a year ago.
CHN Yearly Shares OutstandingCHN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CHN Yearly Total Debt VS Total AssetsCHN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CHN has an Altman-Z score of 132.16. This indicates that CHN is financially healthy and has little risk of bankruptcy at the moment.
The Debt to FCF ratio of CHN is 0.03, which is an excellent value as it means it would take CHN, only 0.03 years of fcf income to pay off all of its debts.
CHN has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Although CHN does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Altman-Z 132.16
ROIC/WACCN/A
WACCN/A
CHN Yearly LT Debt VS Equity VS FCFCHN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.45 indicates that CHN may have some problems paying its short term obligations.
CHN has a Quick Ratio of 0.45. This is a bad value and indicates that CHN is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.45
Quick Ratio 0.45
CHN Yearly Current Assets VS Current LiabilitesCHN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 218.79% over the past year.
Measured over the past years, CHN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.30% on average per year.
Looking at the last year, CHN shows a very strong growth in Revenue. The Revenue has grown by 52.35%.
The Revenue has been decreasing by -8.11% on average over the past years.
EPS 1Y (TTM)218.79%
EPS 3Y36.63%
EPS 5Y-12.3%
EPS Q2Q%-244.44%
Revenue 1Y (TTM)52.35%
Revenue growth 3Y-5.82%
Revenue growth 5Y-8.11%
Sales Q2Q%92.06%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHN Yearly Revenue VS EstimatesCHN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 9.26 indicates a reasonable valuation of CHN.
CHN's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.89.
Industry RankSector Rank
PE 9.26
Fwd PE N/A
CHN Price Earnings VS Forward Price EarningsCHN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 9.5
EV/EBITDA N/A
CHN Per share dataCHN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.82%, CHN is not a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.31, CHN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.82%

5.2 History

The dividend of CHN decreases each year by -50.99%.
CHN has paid a dividend for at least 10 years, which is a reliable track record.
CHN has decreased its dividend recently.
Dividend Growth(5Y)-50.99%
Div Incr Years1
Div Non Decr Years1
CHN Yearly Dividends per shareCHN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6

5.3 Sustainability

7.70% of the earnings are spent on dividend by CHN. This is a low number and sustainable payout ratio.
The Dividend Rate of CHN has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP7.7%
EPS Next 2YN/A
EPS Next 3YN/A
CHN Yearly Income VS Free CF VS DividendCHN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M
CHN Dividend Payout.CHN Dividend Payout, showing the Payout Ratio.CHN Dividend Payout.PayoutRetained Earnings

CHINA FUND INC

NYSE:CHN (10/24/2025, 8:15:14 PM)

After market: 18.22 +0.07 (+0.39%)

18.15

-0.11 (-0.6%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)10-31 2023-10-31
Earnings (Next)N/A N/A
Inst Owners69.81%
Inst Owner Change0%
Ins Owners0.01%
Ins Owner Change0%
Market Cap174.42M
Revenue(TTM)3.98M
Net Income(TTM)18.96M
Analysts0
Price TargetN/A
Short Float %0.05%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield 0.82%
Yearly Dividend0.02
Dividend Growth(5Y)-50.99%
DP7.7%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.26
Fwd PE N/A
P/S 43.82
P/FCF 9.5
P/OCF 9.5
P/B 1.29
P/tB 1.29
EV/EBITDA N/A
EPS(TTM)1.96
EY10.8%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.91
FCFY10.53%
OCF(TTM)1.91
OCFY10.53%
SpS0.41
BVpS14.07
TBVpS14.07
PEG (NY)N/A
PEG (5Y)N/A
Graham Number24.91
Profitability
Industry RankSector Rank
ROA 13.94%
ROE 14.04%
ROCE 1.46%
ROIC 1.15%
ROICexc 1.15%
ROICexgc 1.15%
OM 49.75%
PM (TTM) 476.38%
GM 66.58%
FCFM 461.31%
ROA(3y)-23.62%
ROA(5y)-7.32%
ROE(3y)-24.16%
ROE(5y)-7.37%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y68.22%
ROICexgc growth 5Y9.28%
ROICexc growth 3Y68.22%
ROICexc growth 5Y9.29%
OM growth 3Y37.66%
OM growth 5Y7.39%
PM growth 3Y41.82%
PM growth 5Y-6.33%
GM growth 3Y23.66%
GM growth 5Y3.51%
F-Score8
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.03
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 96.84%
Current Ratio 0.45
Quick Ratio 0.45
Altman-Z 132.16
F-Score8
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)218.79%
EPS 3Y36.63%
EPS 5Y-12.3%
EPS Q2Q%-244.44%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)52.35%
Revenue growth 3Y-5.82%
Revenue growth 5Y-8.11%
Sales Q2Q%92.06%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y296%
EBIT growth 3Y29.65%
EBIT growth 5Y-1.32%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y463.35%
FCF growth 3Y33.69%
FCF growth 5Y-13.94%
OCF growth 1Y463.35%
OCF growth 3Y33.69%
OCF growth 5Y-13.94%

CHINA FUND INC / CHN FAQ

What does CHN do?

China Fund Inc is a US-based company operating in industry. The company is headquartered in Boston, Massachusetts. The China Fund, Inc. (the Fund) is a non-diversified, closed-end management investment company. The Fund’s investment objective is long-term capital appreciation which it seeks to achieve by investing primarily in equity securities of companies for which the principal securities trading market is in the People’s Republic of China (China), of companies for which the principal securities trading market is outside of China, or constituting direct equity investments in companies organized outside of China, that in both cases derive at least 50% of their revenues from goods or services sold or produced, or have at least 50% of their assets, in China and constituting direct equity investments in companies organized in China (Direct Investments). The Fund invests in various sectors, including interactive media and services; broadline retail; banks; hotels, restaurants and leisure; beverages, and insurance. The Fund’s investment manager is Matthews International Capital Management, LLC.


What is the stock price of CHINA FUND INC today?

The current stock price of CHN is 18.15 USD. The price decreased by -0.6% in the last trading session.


What is the ChartMill rating of CHINA FUND INC stock?

CHN has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Would investing in CHINA FUND INC be a good decision?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CHN.